Ian Krop
MD, PhD
Chief of Breast Oncology
👥Biography 个人简介
Dr. Ian Krop is a breast oncologist with expertise spanning ADC development for breast cancer. He has contributed to studies of datopotamab deruxtecan (Dato-DXd) in HR-positive HER2-negative and TNBC and has been a leading investigator in breast cancer ADC trials. His research evaluates TROP2 as an actionable target and examines cross-resistance mechanisms between ADCs.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Ian Krop 的研究动态
Follow Ian Krop's research updates
留下邮箱，当我们发布与 Ian Krop（Yale Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment